Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02144259 · ClinicalTrials.gov registry record · NA
The Impact of Contraception on Postpartum Weight Loss
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02144259: Completed NA study, sponsored by University of Pennsylvania.
NCT02144259 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02144259, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This is a prospective mixed methods study to assess weight changes in women randomized to receive Implanon ® or Depo Provera® (DMPA) immediately postpartum compared to women who choose non-hormonal contraception or no contraception immediately postpartum. After enrollment, subjects return for a visit at 3, 6 and 12 months postpartum to be asked a series of questions, take a pregnancy test, and be weighed. Total length of participation for each subject is 1 year or until pregnancy.
Interventions
- DRUG DMPA immediately postpartum
- DRUG Implanon immediately postpartum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-04 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02144259
The ClinicalTrials.gov registry entry for NCT02144259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DMPA immediately postpartum is the first listed.
NCT02144259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02144259 about?
NCT02144259 is a clinical study titled "The Impact of Contraception on Postpartum Weight Loss". This is a prospective mixed methods study to assess weight changes in women randomized to receive Implanon ® or Depo Provera® (DMPA) immediately postpartum compared to women who choose non-hormonal contraception or no contraception immediately postpartum. After enrollment, subjects return for a visi...
What is the current status of trial NCT02144259?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2011-04. Estimated completion is 2012-10.
What interventions are being tested in trial NCT02144259?
The interventions under investigation include: DMPA immediately postpartum (DRUG), Implanon immediately postpartum (DRUG).
Who is sponsoring clinical trial NCT02144259?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.